What is ActX?
ActX specializes in revolutionizing personalized medical care by seamlessly integrating genetic information into Electronic Health Record (EHR) systems. The company provides real-time genomic decision support tools for healthcare providers, aiming to optimize prescription efficacy and patient safety based on individual genetic profiles. By enabling individuals and healthcare systems to leverage genetic data for more informed medical decisions, ActX is at the forefront of advancing patient-centric healthcare solutions.
How much funding has ActX raised?
ActX has raised a total of $5.9M across 4 funding rounds:
Private Equity
$1.9M
Private Equity
$750K
Private Equity
$3.1M
Debt
$150K
Private Equity (2013): $1.9M, investors not publicly disclosed
Private Equity (2014): $750K, investors not publicly disclosed
Private Equity (2016): $3.1M, investors not publicly disclosed
Debt (2020): $150K featuring PPP
What's next for ActX?
The substantial enterprise-level funding and recent strategic investment signal a pivotal growth phase for ActX. This capital infusion is expected to accelerate the expansion of its genomic decision support services, enhance its technological infrastructure for EHR integration, and broaden its market reach to more healthcare providers and systems. ActX is poised to further solidify its position as a leader in leveraging genetic insights for improved patient outcomes and more effective healthcare delivery.
See full ActX company page